Clinical Trials
7 trialsNCT05150353 2026-06-04
AMYLOCARP
Ramsay Générale de Santé
Phase NA Completed
NCT07626476 2026-06-04
Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
Beijing Boren Hospital
Phase EARLY_PHASE1 Recruiting
NCT07624760 2026-06-03
MGUS-PET
University of Zurich
Phase NA Not yet recruiting
NCT07615270 2026-05-29
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
Stanford University
Phase EARLY_PHASE1 Not yet recruiting
NCT07585331 2026-05-13
Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
Completed
NCT05145816 2026-05-07
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
University of Texas Southwestern Medical Center
Phase 1/2 Recruiting
NCT07448935 2026-05-06
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting